Literature DB >> 11378522

In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry.

I M Van Der Lubben1, F A Konings, G Borchard, J C Verhoef, H E Junginger.   

Abstract

Although oral vaccination has numerous advantages over parenteral injection, degradation of the vaccine and low uptake by the gut associated lymphoid tissue (GALT) still complicate the development of efficient oral vaccines. However, previous studies in our laboratory demonstrated that chitosan microparticles can have suitable size, charge, loading and release characteristics for oral vaccination using ovalbumin as model vaccine. In this study, two different approaches were used to investigate the in vivo uptake of chitosan microparticles by murine Peyer's patches. Firstly, a confocal laser scanning microscopy (CLSM) study was performed to visualize the uptake of fluorescent-labeled chitosan microparticles in the Peyer's patches after intragastrical feeding. Subsequently, the intestinal epithelial uptake of ovalbumin loaded chitosan microparticles was visualized using immunohistochemical staining of ovalbumin. Because the microparticles are biodegradable, this entrapped ovalbumin will be released after intracellular digestion in the Peyer's patches. CLSM visualization demonstrated that chitosan microparticles enhance the uptake of fluorescent-labeled ovalbumin by the epithelium of the Peyer's patches. No ovalbumin uptake by the intestinal epithelium was observed when the protein was administered without microparticles. Moreover, immunohistochemical visualization studies revealed that ovalbumin could only be transported into the Peyer's patches after association to chitosan microparticles. Since uptake by Peyer's patches is an essential step in oral vaccination, these in vivo experiments demonstrate that chitosan microparticles are very promising vaccine delivery systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378522     DOI: 10.3109/10611860108995631

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

1.  Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery.

Authors:  Takahiro Nagamoto; Yoshiyuki Hattori; Kozo Takayama; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Novel antigen delivery technologies: a review.

Authors:  Deepika Jain; Vikas Jain; Ranjit Singh
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

3.  Histopathology Study of Alginate Microspheres Containing Ovalbumin on Liver and Kidney Following Oral Administration and Evaluation of Uptake by Peyer's Plaque.

Authors:  Dewi Melani Hariyadi; Esti Hendradi; Idha Kusumawati; Fauzia Azzahra
Journal:  Turk J Pharm Sci       Date:  2017-11-20

Review 4.  Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review.

Authors:  Mohammad Ariful Islam; Jannatul Firdous; Yun-Jaie Choi; Cheol-Heui Yun; Chong-Su Cho
Journal:  Int J Nanomedicine       Date:  2012-12-13

5.  Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.

Authors:  Sergio A Bucarey; Myriam Pujol; Joaquín Poblete; Ignacio Nuñez; Cecilia V Tapia; Andrónico Neira-Carrillo; Jonatán Martinez; Oliver Bassa
Journal:  Virol J       Date:  2014-08-20       Impact factor: 4.099

Review 6.  Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease.

Authors:  Isabella Anna Joubert; Mark Geppert; Litty Johnson; Robert Mills-Goodlet; Sara Michelini; Evgeniia Korotchenko; Albert Duschl; Richard Weiss; Jutta Horejs-Höck; Martin Himly
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 7.  Chitosan-Based Nanoparticles Against Viral Infections.

Authors:  Homa Boroumand; Fereshteh Badie; Samaneh Mazaheri; Zeynab Sadat Seyedi; Javid Sadri Nahand; Majid Nejati; Hossein Bannazadeh Baghi; Mohammad Abbasi-Kolli; Bita Badehnoosh; Maryam Ghandali; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

8.  New methodologies to characterize the effectiveness of the gene transfer mediated by DNA-chitosan nanoparticles.

Authors:  Miguel N Centelles; Cheng Qian; Miguel A Campanero; Juan M Irache
Journal:  Int J Nanomedicine       Date:  2008

Review 9.  Nanotechnology-based drug delivery systems and herbal medicines: a review.

Authors:  Bruna Vidal Bonifácio; Patricia Bento da Silva; Matheus Aparecido Dos Santos Ramos; Kamila Maria Silveira Negri; Taís Maria Bauab; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2013-12-09

10.  Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles.

Authors:  Zaina Ait Bachir; YuKun Huang; MuYe He; Lei Huang; XinYu Hou; RongJun Chen; Feng Gao
Journal:  Int J Nanomedicine       Date:  2018-09-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.